Suppr超能文献

运动诱发性哮喘

Exercise-induced asthma.

作者信息

Wilkerson L A

机构信息

Center for Family Practice & Sports Medicine, Kissimmee, FL 34741-4100, USA.

出版信息

J Am Osteopath Assoc. 1998 Apr;98(4):211-5.

PMID:9594485
Abstract

Exercise-induced asthma is the phenomenon of transient airflow obstruction, typically 5 to 15 minutes after physical exertion. The increased airway resistance produces a 15% or greater decrease in the forced expiratory volume in 1 second, or in peak expiratory flow rate. Exercise-induced asthma occurs in 90% of individuals with asthma, representing 12% to 15% of the population world-wide. The prevalence of exercise-induced asthma among athletes ranges between 3% and 11%. Several theories of the etiology exist: respiratory heat or water loss (or both), hyperventilation causing discharge of bronchospastic chemical mediators or rebound rewarming of the blood in airway tissues. Treatment is either by pharmacologic or nonpharmacologic means, but medication continues to be the cornerstone of therapy for exercise-induced asthma. beta 2-Specific agonists remain the drugs of choice. Cromolyn sodium and nedocromil sodium are alternatives to the beta 2-agonists, and the combined use of the two classes of agents can provide additive benefits.

摘要

运动诱发性哮喘是一种短暂气流受限现象,通常在体力活动后5至15分钟出现。气道阻力增加会导致一秒用力呼气量或呼气峰值流速下降15%或更多。90%的哮喘患者会发生运动诱发性哮喘,占全球人口的12%至15%。运动员中运动诱发性哮喘的患病率在3%至11%之间。病因有多种理论:呼吸道热量或水分流失(或两者皆有)、过度通气导致支气管痉挛化学介质释放或气道组织中血液的反弹性复温。治疗方法包括药物治疗或非药物治疗,但药物仍然是运动诱发性哮喘治疗的基石。β2特异性激动剂仍然是首选药物。色甘酸钠和奈多罗米钠是β2激动剂的替代药物,两类药物联合使用可提供附加益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验